
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here is one low-volatility stock that could succeed under all market conditions and two that may not deliver the returns you need.
Two Stocks to Sell:
First Interstate BancSystem (FIBK)
Rolling One-Year Beta: 0.51
Tracing its roots back to 1971 and still guided by founding family principles, First Interstate BancSystem (NASDAQ: FIBK) operates a network of community banks across 10 western and midwestern states, offering comprehensive banking services to individuals, businesses, and government entities.
Why Do We Pass on FIBK?
- Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
- Projected 6.5 percentage point efficiency ratio increase over the next year signals its day-to-day expenses will rise
- Performance over the past five years shows its incremental sales were less profitable, as its 1.3% annual earnings per share growth trailed its revenue gains
First Interstate BancSystem’s stock price of $37.17 implies a valuation ratio of 1x forward P/B. To fully understand why you should be careful with FIBK, check out our full research report (it’s free).
Atmus Filtration Technologies (ATMU)
Rolling One-Year Beta: 0.37
Spun out of Cummins in 2023 after 65 years as part of the engine maker, Atmus Filtration Technologies (NYSE: ATMU) manufactures filters for trucks, construction equipment, and agriculture machinery to reduce emissions and protect engines.
Why Are We Wary of ATMU?
- Annual revenue growth of 6.1% over the last five years was below our standards for the industrials sector
- Gross margin of 26.7% reflects its high production costs
At $44.20 per share, Atmus Filtration Technologies trades at 14.2x forward P/E. If you’re considering ATMU for your portfolio, see our FREE research report to learn more.
One Stock to Buy:
Eli Lilly (LLY)
Rolling One-Year Beta: 0.20
Founded in 1876 by a Civil War veteran and pharmacist frustrated with the poor quality of medicines, Eli Lilly (NYSE: LLY) discovers, develops, and manufactures pharmaceutical products for conditions including diabetes, obesity, cancer, immunological disorders, and neurological diseases.
Why Should You Buy LLY?
- Annual revenue growth of 43.1% over the past two years was outstanding, reflecting market share gains this cycle
- Adjusted operating margin expanded by 18.7 percentage points over the last two years as it scaled and became more efficient
- Share buybacks catapulted its annual earnings per share growth to 31.4%, which outperformed its revenue gains over the last five years
Eli Lilly is trading at $1,151 per share, or 27.9x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
